{"id":"synvisc-one","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Transient knee effusion"},{"rate":null,"effect":"Knee stiffness"}]},"_chembl":{"chemblId":"CHEMBL2146317","moleculeType":"Small molecule","molecularWeight":"436.55"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Synvisc-One is a single-injection formulation of hylan G-F 20, a viscoelastic fluid derived from hyaluronic acid. It works by restoring the viscosity and elasticity of synovial fluid in the knee joint, thereby reducing friction between cartilage surfaces and providing shock absorption. This mechanical lubrication and cushioning effect alleviates pain and improves joint function in patients with knee osteoarthritis.","oneSentence":"Synvisc-One is a hyaluronic acid-based viscosupplement that lubricates and cushions the knee joint to reduce pain and improve mobility in osteoarthritis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:10:29.571Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Osteoarthritis of the knee"}]},"trialDetails":[{"nctId":"NCT05727371","phase":"NA","title":"Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"RegenLab France SAS","startDate":"2023-08-21","conditions":"Knee Osteoarthritis","enrollment":280},{"nctId":"NCT05337540","phase":"NA","title":"A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Aptissen SA","startDate":"2024-01-17","conditions":"Osteoarthritis, Osteoarthritis, Knee","enrollment":120},{"nctId":"NCT03484091","phase":"PHASE4","title":"Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2018-04-01","conditions":"Knee Osteoarthritis","enrollment":276},{"nctId":"NCT07110402","phase":"NA","title":"Evaluation of Treatment of Osteoarthritis of the Knee in the Form of Chondromalacia of the Articular Cartilage Treated in the Arthroscopic Technique With the Use of:Autogenous Transplantation of Fragmented Adipose Tissue,PRP GF,Mesenchymal Cells,Hyaluronic Acid-low Molecular Weight and Cross-linked","status":"COMPLETED","sponsor":"eMKa MED Medical Center","startDate":"2022-12-12","conditions":"Osteoarthritis, Knee, Chondral Defect, Chondromalacia, Left Knee","enrollment":150},{"nctId":"NCT07052851","phase":"NA","title":"Performance of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Multi-center Trial","status":"NOT_YET_RECRUITING","sponsor":"Lipo-Sphere","startDate":"2025-07","conditions":"Osteoarthritis, Knee","enrollment":200},{"nctId":"NCT06611098","phase":"NA","title":"New Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Symatese","startDate":"2025-02-21","conditions":"Knee Osteoarthristis","enrollment":134},{"nctId":"NCT03182374","phase":"NA","title":"nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Zimmer Biomet","startDate":"2017-07-14","conditions":"Osteoarthritis, Knee","enrollment":252},{"nctId":"NCT04045431","phase":"NA","title":"Treatment of Knee Osteoarthritis With PAAG-OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Contura","startDate":"2019-05-15","conditions":"Osteoarthritis, Knee","enrollment":238},{"nctId":"NCT05492851","phase":"PHASE4","title":"Trial Comparing Three Single Dose Injections for Knee Osteoarthritis","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2022-08-02","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT05214807","phase":"PHASE4","title":"Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced Symptomatic Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Kiomed Pharma","startDate":"2022-01-26","conditions":"Osteoarthritis, Knee","enrollment":104},{"nctId":"NCT05700253","phase":"NA","title":"Comparing Pain Outcomes of Treatment Strategies for Osteoarthritis Knee Patients","status":"UNKNOWN","sponsor":"Changi General Hospital","startDate":"2023-02","conditions":"Osteoarthritis, Knee, Pain","enrollment":76},{"nctId":"NCT03477630","phase":"PHASE3","title":"Treatment of Osteoarthrosis of the Knee With Platelet Rich Plasma, Comparative Study With Hyaluronic Acid","status":"COMPLETED","sponsor":"Karla Andrea Arias Varela","startDate":"2019-02-14","conditions":"Osteoarthritis","enrollment":28},{"nctId":"NCT02108496","phase":"NA","title":"Verifying the Effectiveness of the NUsurface® System","status":"COMPLETED","sponsor":"Active Implants","startDate":"2014-07","conditions":"Meniscectomy, Osteoarthritis","enrollment":127},{"nctId":"NCT04321668","phase":"NA","title":"Innovative Tool to Analyse Synovial Fluid of Patients With Knee Ostearthritis After IA Injection of Synvisc-one®","status":"COMPLETED","sponsor":"Pulsalys","startDate":"2020-02-12","conditions":"Knee Osteoarthritis, Intra-Articular Injection","enrollment":13},{"nctId":"NCT03190369","phase":"PHASE3","title":"Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2017-08-21","conditions":"Osteoarthritis","enrollment":440},{"nctId":"NCT02136901","phase":"NA","title":"The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System)","status":"COMPLETED","sponsor":"Active Implants","startDate":"2014-06","conditions":"Meniscectomy, Osteoarthritis","enrollment":34},{"nctId":"NCT02674399","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"Nature Cell Co. Ltd.","startDate":"2016-02-16","conditions":"Osteoarthritis, Knee","enrollment":28},{"nctId":"NCT02671565","phase":"","title":"Comparative Effectiveness of Hyaluronic Acid Injections for Management of Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2016-02","conditions":"Knee Osteoarthritis","enrollment":13849},{"nctId":"NCT01625013","phase":"NA","title":"Synvisc-One for Younger, Active Patients With Osteoarthritis","status":"COMPLETED","sponsor":"Anthony Luke","startDate":"2011-11","conditions":"Osteoarthritis","enrollment":51},{"nctId":"NCT00971074","phase":"NA","title":"Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy","status":"WITHDRAWN","sponsor":"Grant Jones","startDate":"2009-12","conditions":"Arthralgia","enrollment":""},{"nctId":"NCT04693104","phase":"NA","title":"Intra-articular PVA Hydrogel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Rottapharm Biotech","startDate":"2019-10-01","conditions":"Knee Osteoarthritis","enrollment":43},{"nctId":"NCT01771952","phase":"NA","title":"Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral Chondromalacia","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2010-03","conditions":"Chondromalacia Patella, Patellofemoral Pain Syndrome","enrollment":86},{"nctId":"NCT04326985","phase":"EARLY_PHASE1","title":"RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2015-01-31","conditions":"Osteoarthritis, Knee","enrollment":20},{"nctId":"NCT03694821","phase":"PHASE4","title":"Knee Injection RCT","status":"TERMINATED","sponsor":"UConn Health","startDate":"2018-07-05","conditions":"Osteoarthritis","enrollment":18},{"nctId":"NCT04198467","phase":"PHASE2","title":"To Evaluate the Optimum Dose of Platelet Rich Plasma in Knee Osteoarthritis and Compare Efficacy With Hyaluronic Acid","status":"COMPLETED","sponsor":"Dr. Himanshu Bansal Foundation","startDate":"2014-10-21","conditions":"Knee Osteoarthritis","enrollment":100},{"nctId":"NCT03328728","phase":"NA","title":"Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Regen Lab SA","startDate":"2017-07-18","conditions":"Knee Osteoarthritis","enrollment":190},{"nctId":"NCT03242707","phase":"NA","title":"Intra-articular Adipose Tissue Injections for Osteoarthritis","status":"UNKNOWN","sponsor":"University of Southern California","startDate":"2018-07-01","conditions":"Osteoarthritis, Knee","enrollment":54},{"nctId":"NCT00949494","phase":"PHASE1","title":"Effects of Synvisc on Cartilage in Knee Osteoarthritis (OA)","status":"COMPLETED","sponsor":"Endeavor Health","startDate":"2006-09","conditions":"Osteoarthritis","enrollment":30},{"nctId":"NCT04018690","phase":"NA","title":"Project Arthritis Recovering Quality of Life Through Education - Hip","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2019-09-01","conditions":"Hip Osteoarthritis","enrollment":48},{"nctId":"NCT04019782","phase":"PHASE3","title":"Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2019-08-01","conditions":"Knee Osteoarthritis, Gonarthrosis","enrollment":120},{"nctId":"NCT02694146","phase":"PHASE3","title":"Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis","status":"COMPLETED","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2016-03","conditions":"Coxarthrosis","enrollment":74},{"nctId":"NCT03800810","phase":"EARLY_PHASE1","title":"Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2015-05","conditions":"Osteoarthritis, Knee","enrollment":9},{"nctId":"NCT03203408","phase":"NA","title":"Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis","status":"COMPLETED","sponsor":"TRB Chemedica","startDate":"2011-06-21","conditions":"Knee Osteoarthritis","enrollment":290},{"nctId":"NCT02389452","phase":"PHASE4","title":"Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2010-02","conditions":"Osteoarthritis","enrollment":394},{"nctId":"NCT00131326","phase":"PHASE3","title":"A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2003-11","conditions":"Osteoarthritis, Hip, Musculoskeletal Diseases","enrollment":""},{"nctId":"NCT00398866","phase":"PHASE3","title":"A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2006-08","conditions":"Osteoarthritis","enrollment":200},{"nctId":"NCT02029703","phase":"NA","title":"Optimization of Synvisc-One for Knee OA","status":"TERMINATED","sponsor":"Elaine Husni","startDate":"2012-08","conditions":"Knee Osteoarthritis","enrollment":42},{"nctId":"NCT00198029","phase":"NA","title":"An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2004-10","conditions":"Carpometacarpal Osteoarthritis","enrollment":32},{"nctId":"NCT02613247","phase":"PHASE2","title":"Intra-articular Hyaluronic Acid Injection for Therapy-resistant Patellofemoral Pain Syndrome","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2016-03","conditions":"Patellofemoral Pain Syndrome","enrollment":50},{"nctId":"NCT01618708","phase":"NA","title":"A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2012-09","conditions":"Osteoarthritis, Hip","enrollment":357},{"nctId":"NCT01810848","phase":"PHASE1","title":"Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity","status":"TERMINATED","sponsor":"OhioHealth","startDate":"2014-06","conditions":"Knee Osteoarthritis","enrollment":9},{"nctId":"NCT01586338","phase":"PHASE4","title":"A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-03","conditions":"Osteoarthritis","enrollment":237},{"nctId":"NCT02686047","phase":"PHASE2, PHASE3","title":"Comparing One Intraarticular Injection of a Novel HYAJOINT Plus With Synvisc-One for the Treatment of Knee OA","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2014-09","conditions":"Knee Osteoarthritis","enrollment":132},{"nctId":"NCT00131352","phase":"PHASE3","title":"A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2005-05","conditions":"Osteoarthritis, Knee, Musculoskeletal Diseases","enrollment":253},{"nctId":"NCT00131300","phase":"PHASE3","title":"A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2004-04","conditions":"Osteoarthritis, Musculoskeletal Diseases","enrollment":""},{"nctId":"NCT00131768","phase":"PHASE3","title":"A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2003-11","conditions":"Osteoarthritis","enrollment":""},{"nctId":"NCT02368561","phase":"EARLY_PHASE1","title":"Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid Injection","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2015-03","conditions":"Insertional Achilles Tendinitis","enrollment":20},{"nctId":"NCT01335321","phase":"PHASE4","title":"Evaluation of the Effect of Adding Corticosteroid to Viscosupplementation","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2011-03","conditions":"Osteoarthritis","enrollment":108},{"nctId":"NCT02195557","phase":"","title":"Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-04","conditions":"Osteoarthritis","enrollment":16},{"nctId":"NCT02197026","phase":"PHASE4","title":"Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-10","conditions":"Osteoarthritis","enrollment":518},{"nctId":"NCT02195492","phase":"","title":"Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-04","conditions":"Osteoarthritis","enrollment":41},{"nctId":"NCT02195505","phase":"","title":"Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-09","conditions":"Osteoarthritis","enrollment":374},{"nctId":"NCT02195544","phase":"","title":"Use of Synvisc® in Knee Osteoarthritis - Survey on Practice","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-10","conditions":"Osteoarthritis","enrollment":70},{"nctId":"NCT01874574","phase":"PHASE4","title":"Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2011-01","conditions":"Knee Osteoarthritis","enrollment":100},{"nctId":"NCT01557868","phase":"PHASE4","title":"Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis","status":"COMPLETED","sponsor":"American Orthopaedic Society for Sports Medicine","startDate":"2008-10","conditions":"Osteoarthritis, Knee","enrollment":198},{"nctId":"NCT01810809","phase":"PHASE4","title":"Hip Viscosupplementation: What is the Best Dosage?","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2013-04","conditions":"Osteoarthritis","enrollment":80},{"nctId":"NCT01748201","phase":"PHASE4","title":"Viscosupplementation in Patients With Hemophilic Arthropathy","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2012-11","conditions":"Osteoarthritis, Hemarthrosis, Hemophilia A","enrollment":13},{"nctId":"NCT00556608","phase":"PHASE4","title":"Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2007-11","conditions":"Osteoarthritis, Knee","enrollment":381},{"nctId":"NCT01210742","phase":"NA","title":"The Efficacy of Viscosupplementation for Early Knee Osteoarthritis","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2011-05","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT01134406","phase":"PHASE2","title":"Hydros Joint Therapy and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis (OA)","status":"COMPLETED","sponsor":"Carbylan Therapeutics, Inc.","startDate":"2010-04","conditions":"Osteoarthritis of the Knee","enrollment":98},{"nctId":"NCT01132677","phase":"NA","title":"A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis","status":"UNKNOWN","sponsor":"LifeMark Health","startDate":"2010-05","conditions":"Osteoarthritis, Knee","enrollment":78},{"nctId":"NCT00312533","phase":"","title":"Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Steadman Hawkins Research Foundation","startDate":"2006-04","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT00078351","phase":"PHASE2","title":"Synvisc to Treat Osteoarthritis of the Temporomandibular Joint","status":"COMPLETED","sponsor":"National Institute of Dental and Craniofacial Research (NIDCR)","startDate":"2004-02","conditions":"Osteoarthritis","enrollment":60},{"nctId":"NCT00393393","phase":"PHASE4","title":"Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee","status":"UNKNOWN","sponsor":"Cabrini Medical Centre","startDate":"2006-01","conditions":"Osteoarthritis","enrollment":80},{"nctId":"NCT00325845","phase":"PHASE3","title":"Synvisc Injections for Lumbar Facet Joint Pain","status":"UNKNOWN","sponsor":"Sheltering Arms Physical Rehabilitation Hospitals","startDate":"2006-05","conditions":"Joint Pain","enrollment":15}],"_emaApprovals":[],"_faersSignals":[{"count":16,"reaction":"PAIN"},{"count":11,"reaction":"ARTHRALGIA"},{"count":8,"reaction":"OSTEOARTHRITIS"},{"count":8,"reaction":"PAIN IN EXTREMITY"},{"count":7,"reaction":"FATIGUE"},{"count":6,"reaction":"DIARRHOEA"},{"count":6,"reaction":"DRUG HYPERSENSITIVITY"},{"count":6,"reaction":"ILL-DEFINED DISORDER"},{"count":6,"reaction":"JOINT SWELLING"},{"count":6,"reaction":"NAUSEA"}],"_approvalHistory":[],"publicationCount":22,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Active Comparator","GZ402662; hylan G-F 20"],"phase":"marketed","status":"active","brandName":"Synvisc-One","genericName":"Synvisc-One","companyName":"Nature Cell Co. Ltd.","companyId":"nature-cell-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Synvisc-One is a hyaluronic acid-based viscosupplement that lubricates and cushions the knee joint to reduce pain and improve mobility in osteoarthritis. Used for Osteoarthritis of the knee.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":5,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}